纽约，2026 年 4 月 27 日/PRNewswire/ -- Rowley Law PLLC 正在调查 XOMA Royalty Corporation (NASDAQ: XOMA) 及其董事会在与 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) 提议收购该公司的过程中可能存在的证券法违规行为。股东将获得每股 XOMA Royalty 股票 39.00 美元和一项附带价值权。该交易的估值约为 7.39 亿美元，预计将在 2026 年第三季度完成。
如果您是 XOMA Royalty Corporation 的股东，并且对获取有关此调查的更多信息感兴趣，请访问我们的网站：http://www.rowleylawpllc.com/investigation/xoma/。您也可以通过电子邮件联系 Rowley Law PLLC 的 Shane Rowley 律师，地址为 50 Main Street Suite 1000, White Plains, NY 10606，电子邮件为 [email protected]，或拨打电话 914-400-1920 或 844-400-4643（免费电话）。
Rowley Law PLLC 在全国范围内代表股东参与复杂公司诉讼中的集体诉讼和衍生诉讼。有关该公司及其律师的更多信息，请访问 http://www.rowleylawpllc.com。
律师广告。之前的结果并不保证类似的结果。
来源 Rowley Law PLLC
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI3Jk5ld3NJdGVtSWQ9Tlk0NDM1MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjcxNTA2UFJfTkVXU19VU1BSX19fX19OWTQ0MzUx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI3Jk5ld3NJdGVtSWQ9Tlk0NDM1MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjcxNTA2UFJfTkVXU19VU1BSX19fX19OWTQ0MzUx"/>

标记临床研究

Rowley Law PLLC 正在调查 XOMA Royalty Corporation（纳斯达克代码：XOMA）及其董事会在 Ligand Pharmaceuticals Incorporated（纳斯达克代码：LGND）拟议收购中的潜在证券法违规行为。股东将每股获得 39.00 美元和一个附带价值权，该交易估值约为 7.39 亿美元，预计将在 2026 年第三季度完成。感兴趣的股东可以联系 Rowley Law PLLC 获取更多信息

NEW YORK, April 27, 2026 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by XOMA Royalty Corporation (NASDAQ: XOMA) and its board of directors concerning the proposed acquisition of the company by Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). Stockholders will receive $39.00 and one contingent value right for each share of XOMA Royalty stock that they hold. The transaction is valued at approximately $739 million and is expected to close in the third quarter of 2026.
<div class="lb-trans">纽约，2026 年 4 月 27 日/PRNewswire/ -- Rowley Law PLLC 正在调查 XOMA Royalty Corporation (NASDAQ: XOMA) 及其董事会在与 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) 提议收购该公司的过程中可能存在的证券法违规行为。股东将获得每股 XOMA Royalty 股票 39.00 美元和一项附带价值权。该交易的估值约为 7.39 亿美元，预计将在 2026 年第三季度完成。
</div>If you are a stockholder of XOMA Royalty Corporation and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/xoma/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
<div class="lb-trans">如果您是 XOMA Royalty Corporation 的股东，并且对获取有关此调查的更多信息感兴趣，请访问我们的网站：http://www.rowleylawpllc.com/investigation/xoma/。您也可以通过电子邮件联系 Rowley Law PLLC 的 Shane Rowley 律师，地址为 50 Main Street Suite 1000, White Plains, NY 10606，电子邮件为 [email protected]，或拨打电话 914-400-1920 或 844-400-4643（免费电话）。
</div>Rowley Law PLLC represents stockholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
<div class="lb-trans">Rowley Law PLLC 在全国范围内代表股东参与复杂公司诉讼中的集体诉讼和衍生诉讼。有关该公司及其律师的更多信息，请访问 http://www.rowleylawpllc.com。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律师广告。之前的结果并不保证类似的结果。
</div>SOURCE Rowley Law PLLC
<div class="lb-trans">来源 Rowley Law PLLC
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI3Jk5ld3NJdGVtSWQ9Tlk0NDM1MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjcxNTA2UFJfTkVXU19VU1BSX19fX19OWTQ0MzUx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY44351&amp;Transmission_Id=202604271506PR_NEWS_USPR_____NY44351&amp;DateId=20260427"/>

15:06 ETALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

15:06 ET 警报：Rowley Law PLLC 正在调查拟议收购标记临床研究公司的情况